/PRNewswire/ Advent Life Sciences, a leading transatlantic venture and growth investor focused on building innovative life science companies in the UK,.
Advent Life Sciences Announces Close of Two New Funds Totalling $215 million to Translate Early-Stage Research into Impactful Medicines for Patients prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.